Bayer Makes $20 Billion Offer for Schering

In a bid that could help partly restore Germany’s historic prominence in the pharmaceutical industry, the drug and chemical giant Bayer late Thursday announced a nearly $20 billion offer for its smaller rival, Schering, topping a $17.9 billion offer by Merck of Germany